RPHCF

Rohto Pharmaceutical Co.,Ltd.

USD

Set alert

Price alert · RPHCF

All alert types
17.20 USD 0.00 0.00%
As of Oct 29, 2026
15.20 Day range 15.20
14.34 52-week range 17.20
YTD
+5.50%
1 year
+16.82%
Open
15.20
Prev close
17.20
Mkt cap
3.87B
Vol
150
Avg vol
2
EPS
0.91
P/E
18.90
More statistics
Low
15.20
High
15.20
Earnings
Nov 12, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for RPHCF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.42 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 15.9×
FY 2017: 58.3×FY 2018: 59.8×FY 2019: 137×FY 2020: 83.7×FY 2021: 90.8×FY 2022: 19.6×FY 2023: 19.8×FY 2024: 22.9×FY 2025: 22.1×FY 2026: 15.9×
FY 2017 5y median 19.8× FY 2026
P/S 1.6×
FY 2017: 3.7×FY 2018: 3.2×FY 2019: 7.3×FY 2020: 6.9×FY 2021: 8.4×FY 2022: 2.1×FY 2023: 2.2×FY 2024: 2.6×FY 2025: 2.2×FY 2026: 1.6×
FY 2017 5y median 2.2× FY 2026
P/B 1.8×
FY 2017: 4.9×FY 2018: 4.3×FY 2019: 10.2×FY 2020: 1007×FY 2021: 9.7×FY 2022: 283×FY 2023: 2.5×FY 2024: 2.9×FY 2025: 2.6×FY 2026: 1.8×
FY 2017 5y median 2.6× FY 2026
P/FCF 14.9×
FY 2017: 6794×FY 2018: 4269×FY 2019: 10039×FY 2020: 11127×FY 2021: 17308×FY 2022: 3170×FY 2023: 3308×FY 2024: 28.0×FY 2025: 26.0×FY 2026: 14.9×
FY 2017 5y median 28.0× FY 2026
EV/EBITDA 8.9×
FY 2017: 27.9×FY 2018: 24.3×FY 2019: 59.1×FY 2020: 43.8×FY 2021: 51.1×FY 2022: 12.2×FY 2023: 10.7×FY 2024: 12.5×FY 2025: 11.7×FY 2026: 8.9×
FY 2017 5y median 11.7× FY 2026
EV/Sales 1.5×
FY 2017: 3.8×FY 2018: 3.2×FY 2019: 7.3×FY 2020: 6.7×FY 2021: 8.4×FY 2022: 2.2×FY 2023: 1.9×FY 2024: 2.3×FY 2025: 2.1×FY 2026: 1.5×
FY 2017 5y median 2.1× FY 2026
FCF Yield 6.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 3.6%FY 2025: 3.8%FY 2026: 6.7%
FY 2017 5y median 3.6% FY 2026

Profitability

Gross Margin 53.2%
FY 2017: 0.5%FY 2018: 0.5%FY 2019: 0.5%FY 2020: 0.6%FY 2021: 58.9%FY 2022: 58.2%FY 2023: 57.6%FY 2024: 58.1%FY 2025: 56.7%FY 2026: 53.2%
FY 2017 5y median 57.6% FY 2026
Operating Margin 11.8%
FY 2017: 10.0%FY 2018: 11.1%FY 2019: 11.3%FY 2020: 12.3%FY 2021: 12.7%FY 2022: 14.5%FY 2023: 14.2%FY 2024: 14.8%FY 2025: 12.6%FY 2026: 11.8%
FY 2017 5y median 14.2% FY 2026
Net Margin 10.0%
FY 2017: 6.5%FY 2018: 5.4%FY 2019: 5.3%FY 2020: 8.2%FY 2021: 9.2%FY 2022: 10.6%FY 2023: 11.1%FY 2024: 11.4%FY 2025: 10.0%FY 2026: 10.0%
FY 2017 5y median 10.6% FY 2026
ROE 11.3%
FY 2017: 8.5%FY 2018: 7.3%FY 2019: 7.5%FY 2020: 1194.4%FY 2021: 10.7%FY 2022: 1441.6%FY 2023: 12.6%FY 2024: 12.6%FY 2025: 11.9%FY 2026: 11.3%
FY 2017 5y median 12.6% FY 2026
ROIC 7.6%
FY 2017: 20.3%FY 2018: 19.7%FY 2019: 20.8%FY 2020: 10.4%FY 2021: -32.2%FY 2022: 227.3%FY 2023: 443.3%FY 2024: 11.5%FY 2025: 8.5%FY 2026: 7.6%
FY 2017 5y median 11.5% FY 2026
ROA 7.1%
FY 2017: 614.5%FY 2018: 498.5%FY 2019: 539.7%FY 2020: 7.1%FY 2021: 818.1%FY 2022: 935.6%FY 2023: 1131.6%FY 2024: 8.9%FY 2025: 7.3%FY 2026: 7.1%
FY 2017 5y median 8.9% FY 2026

Growth (YoY)

Revenue 12.1%
FY 2017: -7.1%FY 2018: 11.1%FY 2019: 6.9%FY 2020: 2.6%FY 2021: -3.9%FY 2022: 10.3%FY 2023: 19.5%FY 2024: 13.5%FY 2025: 14.0%FY 2026: 12.1%
FY 2017 FY 2026
Operating Income 5.2%
FY 2017: -1.5%FY 2018: 23.5%FY 2019: 9.0%FY 2020: 10.9%FY 2021: -0.4%FY 2022: 26.2%FY 2023: 17.0%FY 2024: 17.9%FY 2025: -2.8%FY 2026: 5.2%
FY 2017 FY 2026
EPS (diluted) 8.5%
FY 2017: 10.6%FY 2018: -7.1%FY 2019: 7.0%FY 2020: 55.0%FY 2021: 9.3%FY 2022: 26.2%FY 2023: 24.9%FY 2024: 17.3%FY 2025: 0.2%FY 2026: 8.5%
FY 2017 FY 2026
Free Cash Flow 38.6%
FY 2017: 44.5%FY 2018: 52.0%FY 2019: 4.0%FY 2020: -12.8%FY 2021: -24.8%FY 2022: 48.9%FY 2023: 20.9%FY 2024: 15914.5%FY 2025: 4.0%FY 2026: 38.6%
FY 2017 FY 2026

Financial Health

Current Ratio 2.0×
FY 2017: 1.9×FY 2018: 1.8×FY 2019: 1.9×FY 2020: 2.1×FY 2021: 0.0×FY 2022: 2.3×FY 2023: 2.4×FY 2024: 2.5×FY 2025: 2.3×FY 2026: 2.0×
FY 2017 5y median 2.3× FY 2026
Quick Ratio 1.5×
FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 1.6×FY 2021: -0.5×FY 2022: 1.8×FY 2023: -65.7×FY 2024: 1.9×FY 2025: 1.7×FY 2026: 1.5×
FY 2017 5y median 1.7× FY 2026
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 5.7×FY 2021: 0.1×FY 2022: 14.6×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.2×FY 2026: 0.2×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA -0.5×
FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.2×FY 2020: -1.3×FY 2021: 0.3×FY 2022: 0.6×FY 2023: -1.6×FY 2024: -1.6×FY 2025: -0.5×FY 2026: -0.5×
FY 2017 5y median -0.5× FY 2026
Interest Coverage 31.7×
FY 2017: 114×FY 2018: 133×FY 2019: 141×FY 2020: 185×FY 2021: 159×FY 2022: 117×FY 2023: 137×FY 2024: 204×FY 2025: 41.0×FY 2026: 31.7×
FY 2017 5y median 117× FY 2026

Dividends

Dividend Yield 1.7%
FY 2017: 0.4%FY 2018: 0.5%FY 2019: 0.2%FY 2020: 0.2%FY 2021: 0.2%FY 2022: 0.8%FY 2023: 0.9%FY 2024: 0.8%FY 2025: 1.0%FY 2026: 1.7%
FY 2017 5y median 0.9% FY 2026
Payout Ratio 27.0%
FY 2017: 22.8%FY 2018: 27.0%FY 2019: 25.6%FY 2020: 20.0%FY 2021: 17.7%FY 2022: 16.2%FY 2023: 17.7%FY 2024: 17.7%FY 2025: 22.8%FY 2026: 27.0%
FY 2017 5y median 17.7% FY 2026

Annual · latest fiscal year ends 2026-03-31